- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 177 East Colorado Boulevard, 11th Floor Pasadena CA United States of America 91105
- IPO Date
- Nov 3, 2004
- Business
- PRIMECAP Odyssey Growth Fund (POGRX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in common stocks of U.S. companies with above-average earnings growth potential; it targets stocks across all market sectors and capitalizations, with a historical emphasis on large- and mid-cap companies alongside significant small-cap exposure, and may include foreign securities via depository receipts or foreign exchange-traded stocks. The fund employs a bottom-up stock selection process managed by PRIMECAP Management Company, focusing on growth catalysts such as new products, markets, management changes, restructurings, or industry shifts; top holdings as of recent filings include Eli Lilly and Company, BeOne Medicines Ltd, Micron Technology Inc, Alphabet Inc, and Xometry Inc, with sector allocations led by health care (25.7%), information technology (25.0%), and industrials (18.5%). Launched on November 1, 2004, with assets under management of approximately $5.15 billion, $4.97 billion, or $4.76 billion per various recent reports, the fund maintains a net expense ratio of 0.66%, a portfolio turnover ratio of 11%, and 183 holdings, distributed mainly in the United States (85.5%) with some non-U.S. exposure.
Managed by PRIMECAP Management Company, founded in 1983 and headquartered in Pasadena, California, the fund adheres to the firm's principles of individual decision-making, fundamental research, long-term horizons, and value focus across its U.S.-centric equity portfolios for institutions and mutual funds. PRIMECAP Odyssey Growth Fund operates within the large blend or large growth category, available to U.S. investors with a minimum initial investment of $2,000 ($1,000 for IRAs), and pays dividends and capital gains annually in December.
Recent portfolio adjustments include new positions in UnitedHealth Group Incorporated, Capital One Financial Corporation, Seagate Technology Holdings plc, Fair Isaac Corporation, and Welltower Inc, reflecting ongoing active management and sector rotations amid market dynamics as of mid-2025 SEC filings. The fund has sustained strong performance, with YTD returns around 31.52% or 22.54% per quarterly data through 2025, outperforming the S&P 500 in multiple periods, alongside maintained low fees and high active share of 77%. No major acquisitions, partnerships, funding rounds, or structural reorganizations have been reported for the fund or its advisor in the last 1-2 years.